| Name | Vorolanib |
|---|---|
| Synonyms | X-082 |
| Description | Vorolanib (CM082; X-82) is an orally active, multikinase VEGFR/PDGFR inhibitor. Vorolanib minimizes toxicity, disrupts tumor angiogenesis and tumor cell proliferation, and induces of tumor cell death[1]. |
|---|---|
| Related Catalog | |
| Target |
VEGFR, PDGFR[1] |
| References |
| Molecular Formula | C23H26FN5O3 |
|---|---|
| Molecular Weight | 439.48 |